Vivani Medical Inc.
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease and medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatid… Read more
Vivani Medical Inc. (VANI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -4.852x
Based on the latest financial reports, Vivani Medical Inc. (VANI) has a cash flow conversion efficiency ratio of -4.852x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.35 Million) by net assets ($1.31 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Vivani Medical Inc. - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Vivani Medical Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Vivani Medical Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Vivani Medical Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MGI Digital Technology Société Anonyme
PINK:FRIIF
|
0.008x |
|
Definitive Healthcare Corp
NASDAQ:DH
|
0.007x |
|
Reach Ten Holdings Berhad
KLSE:5332
|
0.096x |
|
Qua Granite Hayal Yapi ve Urunleri Sanayi Ticaret AS
IS:QUAGR
|
-0.007x |
|
Bixolon Co. Ltd
KQ:093190
|
0.018x |
|
Chun Yu Works & Co Ltd
TW:2012
|
0.007x |
|
Blinklab Ltd
AU:BB1
|
-0.642x |
|
NextSource Materials Inc
OTCQB:NSRCF
|
-0.124x |
Annual Cash Flow Conversion Efficiency for Vivani Medical Inc. (2012–2024)
The table below shows the annual cash flow conversion efficiency of Vivani Medical Inc. from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $17.61 Million | $-20.79 Million | -1.180x | -3.40% |
| 2023-12-31 | $20.76 Million | $-23.70 Million | -1.142x | -169.22% |
| 2022-12-31 | $44.31 Million | $-18.79 Million | -0.424x | +90.46% |
| 2021-12-31 | $2.46 Million | $-10.95 Million | -4.443x | -13.70% |
| 2020-12-31 | $1.95 Million | $-7.62 Million | -3.907x | -2.88% |
| 2019-12-31 | $7.28 Million | $-27.63 Million | -3.798x | +60.71% |
| 2018-12-31 | $3.08 Million | $-29.81 Million | -9.666x | -218.15% |
| 2017-12-31 | $7.88 Million | $-23.95 Million | -3.038x | -35.12% |
| 2016-12-31 | $11.15 Million | $-25.07 Million | -2.248x | -121.77% |
| 2015-12-31 | $20.27 Million | $-20.55 Million | -1.014x | -105.34% |
| 2014-12-31 | $34.62 Million | $-17.09 Million | -0.494x | -126.13% |
| 2013-12-31 | $-9.22 Million | $-17.43 Million | 1.890x | -62.45% |
| 2012-12-31 | $-3.04 Million | $-15.32 Million | 5.034x | -- |